Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial

Table 2

Pharmacotherapeutic agents by target category and by class.

Pharmacotherapeutic agent	Total; ()	Female; ()	Male; ()	value
Antidiabetes agents
Any diabetes drug	91.4%	92.1%	91.1%	0.44
Insulin sensitizing	60.9%	57.7%	62.3%	0.04
Metformin	54.1%	50.2%	55.7%	0.02
TZD	18.8%	16.4%	19.8%	0.06
Insulin Providing	75.6%	77.8%	74.7%	0.11
Sulfonylurea	53.6%	47.7%	56.0%	<0.001
Meglitinide	0.7%	1.0%	0.6%	0.29
Insulin	27.8%	36.3%	24.3%	<0.001
Lipid lowering agents
Any lipid drug	79.1%	77.3%	79.9%	0.16
Statin	74.7%	73.0%	75.4%	0.22
Fibrate	8.6%	6.3%	9.6%	0.01
Niacin	2.2%	1.5%	2.4%	0.14
Blood pressure agents
Any blood pressure drug	95.8%	95.8%	95.8%	1.00
ACE or ARB	77.1%	75.6%	77.7%	0.27
Beta-blocker	72.9%	74.3%	72.3%	0.32
Calcium channel blocker	31.4%	33.9%	30.4%	0.10
Diuretic	38.7%	49.9%	34.0%	<0.001
Antiplatelet/anticoagulants
Any antiplatelet/anticoagulant	91.9%	90.5%	92.5%	0.10
Aspirin	88.0%	85.7%	89.0%	0.03
Ticlopidine/clopidogrel	18.0%	18.8%	17.6%	0.49

ACE = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker.